Category Archives: Oncology

Denmark population-wide study confirms association between cyproterone acetate and meningioma risk – and recent users of CPA are disproportionately trans women

Previously: Additional data confirms 10mg of cyproterone acetate (CPA) is effective for testosterone suppression in trans women (June 2021) Disclaimer: I am not a medical professional and this is not medical advice. Since 2018, I’ve been covering emerging findings on … Continue reading

Posted in Antiandrogens, Endocrinology, Oncology, Progestogens, Transfeminine, Transgender medicine | Tagged , , , | Leave a comment

Additional data confirms 10mg of cyproterone acetate (CPA) is effective for testosterone suppression in trans women

Previously: Lower doses of cyproterone acetate may be similarly effective for blocking testosterone, with a lower risk of adverse effects (August 2020) Study of entire French population offers further data on cyproterone acetate and meningioma risk (February 2021) Disclaimer: I … Continue reading

Posted in Antiandrogens, Endocrinology, Oncology, Progestogens, Transgender medicine | Tagged , , | Leave a comment

Three decades and hundreds of transfeminine breast augmentations show rare regret and trends toward larger implants

Trans women and transfeminine people seeking breast augmentation as part of medical transition face certain concerns distinct from cis women who may receive this surgery. Our anatomical baseline is very different from that of adult cis women, with a recent … Continue reading

Posted in Breast, Oncology, Outcomes of transition, Surgery, Transfeminine, Transgender medicine | Tagged , | Leave a comment

Study of entire French population offers further data on cyproterone acetate and meningioma risk

Previously: Cyproterone acetate and meningioma risk in trans women (March 2018) Update on case reports: Cyproterone acetate and meningioma in trans women (November 2018) Lower doses of cyproterone acetate may be similarly effective for blocking testosterone, with a lower risk … Continue reading

Posted in Antiandrogens, Endocrinology, Oncology, Progestogens | Tagged , , | Leave a comment

Update on cases of lymphoma linked to textured breast implants in transgender women (BIA-ALCL)

I’ve previously covered emerging findings on breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL), a type of non-Hodgkin’s lymphoma caused by the textured surfaces of some implants used in breast augmentation surgeries. Textured surfaces have been used in some breast implants to … Continue reading

Posted in Breast, Health care, Oncology, Surgery, Transfeminine | Tagged , | Leave a comment